Probenecid: An Oral Inotrope for End-Stage Heart Failure in a Case With Myotonic Dystrophy

A 56-year-old man with multiple cardiac manifestations of type 1 myotonic dystrophy, including severe, nonischemic cardiomyopathy… A 56-year-old man with multiple cardiac manifestations of type 1 myotonic dystrophy, including severe, nonischemic cardiomyopathy, presented in refractory cardiogenic sh...

Full description

Saved in:
Bibliographic Details
Published in:JACC. Case reports 2019-08, Vol.1 (2), p.213-217
Main Authors: Klein, Evan C., Rubinstein, Jack, Strande, Jennifer L.
Format: Article
Language:English
Subjects:
Case Report
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A 56-year-old man with multiple cardiac manifestations of type 1 myotonic dystrophy, including severe, nonischemic cardiomyopathy… A 56-year-old man with multiple cardiac manifestations of type 1 myotonic dystrophy, including severe, nonischemic cardiomyopathy, presented in refractory cardiogenic shock requiring inotropic therapy. Given his wishes to die without having any intravenous medications, he was started on oral probenecid therapy, which allowed for successful elimination of his intravenous therapies. ( Level of Difficulty: Intermediate. )
ISSN:2666-0849
DOI:10.1016/j.jaccas.2019.07.008